Trial NCT05395052

View at ClinicalTrials.gov 
Org. Study IDs: FT536-101

Last trial update was posted on 2023-09-21

MeSH Interventions

Amivantamab-vmjw Atezolizumab Avelumab Cetuximab Cyclophosphamide Fludarabine Interleukin-2 Nivolumab Pembrolizumab Trastuzumab

MeSH Conditions


Other Conditions

Breast Cancer Colorectal Cancer GastroEsophageal Cancer Head and Neck Cancer Non Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer

Stopping Reasons

This study was terminated by the Sponsor.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID